GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Advanced Medical Solutions Group PLC (FRA:AQA) » Definitions » 6-1 Month Momentum %

Advanced Medical Solutions Group (FRA:AQA) 6-1 Month Momentum % : -10.26% (As of May. 23, 2024)


View and export this data going back to . Start your Free Trial

What is Advanced Medical Solutions Group 6-1 Month Momentum %?

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2024-05-23), Advanced Medical Solutions Group's 6-1 Month Momentum % is -10.26%.

The industry rank for Advanced Medical Solutions Group's 6-1 Month Momentum % or its related term are showing as below:

FRA:AQA's 6-1 Month Momentum % is ranked worse than
54.2% of 869 companies
in the Medical Devices & Instruments industry
Industry Median: -7.69 vs FRA:AQA: -10.26

Competitive Comparison of Advanced Medical Solutions Group's 6-1 Month Momentum %

For the Medical Instruments & Supplies subindustry, Advanced Medical Solutions Group's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Advanced Medical Solutions Group's 6-1 Month Momentum % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Advanced Medical Solutions Group's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where Advanced Medical Solutions Group's 6-1 Month Momentum % falls into.



Advanced Medical Solutions Group  (FRA:AQA) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Advanced Medical Solutions Group  (FRA:AQA) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.


Advanced Medical Solutions Group 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of Advanced Medical Solutions Group's 6-1 Month Momentum % provided by GuruFocus.com. Please click on the following links to see related term pages.


Advanced Medical Solutions Group (FRA:AQA) Business Description

Traded in Other Exchanges
Address
Premier Park, 33 Road One, Winsford Industrial Estate, Winsford, Cheshire, GBR, CW7 3RT
U.K.-based Advanced Medical Solutions was founded in 1991 to design, develop, and manufacture advanced wound-care products for other healthcare manufacturers. AMS' key branded products include the ActivHeal franchise of hydrogel, hydrocolloid, foam, and alginate wound dressings. The firm also manufactures and markets a suite of branded products in surgical use, including the LiquiBand franchise for tissue adhesion and the Resorba line of sutures and collagen-based products for tissue repair. The firm derives approximately 60% of total revenue from branded products, with nonbranded contributing 40%.

Advanced Medical Solutions Group (FRA:AQA) Headlines

No Headlines